Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neoplasms malignant site unspecified NEC
ADR ID BADD_A03009
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
Description Not Available
MedDRA Code 10029105
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00785Epirubicin hydrochloride--
BADD_D00793Equilin sulfate--
BADD_D00794Ergocalciferol0.000684%
BADD_D00798Eribulin0.010801%
BADD_D00800Erlotinib0.011708%
BADD_D00821Estradiol0.000092%
BADD_D00831Estrogens--
BADD_D00836Estropipate--
BADD_D00853Etophos--
BADD_D00854Etoposide0.000280%
BADD_D00856Etoricoxib--
BADD_D00857Etravirine0.019660%
BADD_D00858Everolimus0.069349%
BADD_D00861Exemestane0.026560%
BADD_D00864Ezetimibe0.000094%
BADD_D00869Famotidine0.000431%
BADD_D00879Fentanyl0.004652%
BADD_D00891Fesoterodine0.000992%
BADD_D00898Finasteride0.000315%
BADD_D00906Florbetapir--
BADD_D00912Fluconazole--
BADD_D00914Fludarabine0.001533%
BADD_D00931Fluorouracil0.002665%
BADD_D00943Flutamide--
BADD_D00946Fluticasone furoate--
BADD_D00947Fluticasone propionate--
BADD_D00952Folic acid--
BADD_D00963Fosaprepitant dimeglumine--
BADD_D00978Fulvestrant0.050886%
BADD_D00979Furosemide0.000014%
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 14 Pages